Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Inosinic acid has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Adding inosinate lets a formulator hold perceived savouriness while cutting added salt, because umami intensity partly substitutes for the sensation salt provides. The compound itself is supplied as a sodium salt, so it contributes a small amount of sodium back. Net sodium usually still falls because the substitution ratio is favourable. This is a formulation lever, not a physiological effect.
Inosinate is a purine nucleotide, and its breakdown runs through hypoxanthine and xanthine to urate. Xanthine oxidoreductase, the enzyme that catalyses both of those steps, carries a molybdenum cofactor. Without adequate molybdenum the enzyme cannot function, which is textbook biochemistry rather than a supplement interaction. Dietary molybdenum deficiency is rare in people eating ordinary food.
Ascorbate competes with urate at the URAT1 transporter in the kidney tubule, which increases urate excretion and modestly lowers serum urate. Since inosinate is a dietary purine that ends in urate, the two act in opposite directions on the same pool. The size of the vitamin C effect is small. It is a directional point about shared handling, not a strategy.
Inosinate is the first complete purine nucleotide the body builds, and it is assembled on a ribose-5-phosphate backbone supplied as PRPP from the pentose phosphate pathway. Ribose feeds that pool. Every adenine and guanine nucleotide in the body is made downstream of inosine monophosphate, which is why this molecule sits at the branch point of purine synthesis.
During hard contraction, when ATP resynthesis falls behind, adenylate kinase and AMP deaminase push AMP toward inosine monophosphate, and muscle inosinate rises. Phosphocreatine buffers ATP during exactly those first seconds, so a well-loaded creatine pool blunts the drop that drives that reaction. The relationship is about intramuscular nucleotide handling and does not imply that swallowing inosinate does anything for exercise.
Nothing specific on file for Inosinic acid. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 2 we read for Inosinic acid. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.